5.4 HIV-induced neurological disease

Medical Journal of Australia

Volumn 164, Issue 7, 1996, Pages 414-417

  Wright, Edwina J ^a,b   Brew, Bruce J ^a,c,d   Currie, Jon N ^a,e,f   McArthur, Justin C ^a  

^a FAIRFIELD HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Department of Neurology ^*

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; REVIEW; VIROLOGY; ARTICLE; CEREBROVASCULAR DISEASE; DEMENTIA; HEADACHE; MYOPATHY; NEUROLOGICAL COMPLICATION; SEIZURE; SPINAL CORD DISEASE;

AIDS DEMENTIA COMPLEX; ANTIVIRAL AGENTS; BRAIN DISEASES; HIV INFECTIONS; HUMANS; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; ZIDOVUDINE;

EID: 0030119419     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122090.x     Document Type: Article

References (31)

1. McArthur JC, Hoover DR, Bacellar H, et al Dementia in AIDS patients, incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993, 43 2245-2252
2. Portegies P, Enting RH, de Gans GJ, et al Presentation and course of AIDS dementia complex, 10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993, 7: 669-675
3. Sidtis JJ, Price RW. Early HIV-1 infection and the AIDS dementia complex [comment] Neurology 1990; 40: 323-326.
4. Currie J, Benson E, Ramsden B, et al. Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex [see comments] Arch Neurol 1988, 45. 949-953
5. Maruff P, Currie J, Malone V, et al Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery Arch Neurol 1994, 51: 689-695.
6. Brew BJ, Bhalla RB, Paul M, et al Cerebrospinal fluid P2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS 1992; 5: 461-465
7. Epstein LG, Gendelman HE Human immunodeficiency virus type 1 infection of the nervous system, pathogenetic mechanisms Ann Neurol 1993, 33. 429-436
8. Power C, McArthur JC, Johnson RT, et al. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68: 4643-4649
9. Hamilton JD, Hartigan PM, Simberkoff MS, et al A controlled trial of early versus late treatment witn zidovudine in symptomatic human immunodeficiency virus infection Results of the Veterans Affairs Cooperative Study [see comments] N Engl J Med 1992, 326. 437-443.
10. Nordic Medical Research Councils' HIV Therapy Group Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. BMJ 1992: 304 13-17.
11. Burger DM, Kraaijeveld CL, Meenhorst PL, et al. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV AIDS 1993, 7 1581-1587
12. Sidtis JJ, Gatsonis C, Price RW, et al Zidovudine treatment of the AIDS dementia complex; results of a placebo-controlled trial AIDS Clinical Trials Group Ann Neurol 1993; 33 343-349
13. Brew BJ, Dunbar N, Druett J Pilot study of the efficacy of Ateviridine in AIDS Dementia Complex (ADC) Tenth International AIDS Conference, Yokohama, Japan 1994. [Abstract 232B.]
14. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy, an autopsy-based case-controlled study Neurology 1994; 44 2159-2164
15. Rosenblum M, Scheck AC, Cronin K, et al Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 1989, 39. 892-896
16. Wesselingh SL, Power C, Fox R, et al Cytokine mRNA expression in HIV-associated neurological disease [abstract] Neurology 1993, 43 Suppl 2 A291
17. So YT, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficiency syndrome Prevalence and clinical features from a population-based survey Arch Neurol 1988, 45 945-948
18. Fuller GN, Jacobs JM, Guiloff RJ Nature and incidence of peripheral nerve syndromes in HIV infection J Neurol Neurosurg Psychiatry 1993, 56 372-381
19. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases Multicenter AIDS Cohort Study, 1985-1992 Neurology 1994, 44 1892-1900.
20. Cornblath DR, McArthur JC Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38 794-796
21. Griffin JW, Wesselingh S, Oaklander AL, et al mRNA fingerprinting of cytokines and growth factors, a new means of characterizing nerve biopsies [abstract] Neurology 1993; 43 Suppl 2 A232
22. Cornblath DR Treatment of the neuromuscular complications of human immunodeficiency virus infection Ann Neurol 1988, 23 Suppl S88-S91
23. Cornblath DR, Chaudhry V, Griffin JW Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin Ann Neurol 1991, 30 104-106.
24. So YT, Olney RK. The natural history of mononeuropathy multiplex and simplex in patients with HIV infection Neurology 1991, 41 Suppl 1 375.
25. Wong MC, Suite ND, Labar DR Seizures in human immunodeficiency virus infection Arch Neurol 1990, 47. 640-642
26. Holtzman DM, Kaku DA, So YT New-onset seizures associated with human immunodeficiency virus infection causation and clinical features in 100 cases. Am J Med 1989, 87 173-177
27. Dore G, Brew BJ Prospective analysis of HIV associated seizures Sixth Conference of the Australian Society of HIV Medicine. Sydney. Australia 1994, [Available from ASHM on request.]
28. Berger JR, Harris JO, Gregorios J, Norenberg M Cerebrovascular disease in AIDS. a case-control study. AIDS 1990, 4 239-244
29. Brew BJ, Miller J Transient ischaemic attacks (TIAs) in HIV infection. Fifth Conference of the Australian Society of HIV Medicine. Melbourne, Australia. 1993. Clin Neuropathol 1993, 12 Suppl S15
30. Simpson DM, Citak KA, Godfrey E, et al Myopathies associated with human immunodeficiency virus and zidovudine can their effects be distinguished? Neurology 1993, 43 971-976
31. Hassett J, Godbold J, Godfrey E, et al A placebo-controlled study of prednisone in HIV-associated myopathy [abstract] Neurology 1994; 44 Suppl 2, A250.